October 18 (Wed)

Pre-congress

Date & Time	October 18 (Wed), 10:30-16:30	Venue	Cosmos Hall (3F)	Language	English
	Session 1. Hba1c Chair GYe Cheol Kwon, Chungnam National University College of Medicine, Korea Speaker Hemoglobin a1c: Standardization, analytical performance and interpretation Emma English, University of East Anglia, IFCC C-EUBD, UK Hb variants in Korea: Effect on Hba1c using five routine methods Junghan Song, Seoul National University College of Medicine, Korea Session Session 2. Thyroid Chair Jeong-Ho Kim, Yonsei University College of Medicine, Korea Speaker IFCC harmonization and standardization efforts for thyroid testing Dusanka Kasapic, Roche Diagnostics, Medical & Scientific Affairs, Switzerland Viola Westrich, Roche Diagnostics, International Product Manager Thyroid, Switzerland The clinical value of bio-markers in thyroid autoimmune diseases and cancers Luca Giovanella, EOC Competence Centre for Thyroid Diseases, Switzerland

Symposium 01

Education track

Overview:
According to the revised eligibility criteria policy, the specialized education of each division will be needed in addition to common education course. Therefore, this session aims to admitted professional qualities required as an educational supervisor and a resident in training and to improve the problem solving capabilities when working in the laboratory. The special divisions covered in this session are clinical chemistry, transplantation immunology, clinical microbiology and transfusion medicine.

Date & Time	October 18 (Wed), 13:00-15:00	Venue	Grand Hall A (B1)	Language	Korean
Chairs	Seok Lae Chae, College of Medicine, Dongguk University, Korea Dongeun Yong, Yonsei University College of Medicine, Korea
Speakers	1.Classification and interpretation of GIT-related tests Hyung-Doo Park, Sungkyunkwan University School of Medicine, Korea 2.Tumor markers- Laboratory tests used in cancer diagnosis Wonmok Lee, Keimyung University School of Medicine, Korea 3.Overview of blood culture: Key elements in CLSI guideline and rapid detection methods Kyeong Seob Shin, Chungbuk National University College of Medicine, Korea 4.Update guideline and strategy for platelet transfusion Jihyang Lim, The Catholic University of Korea, College of Medicine, Korea

Symposium 02

Practical aspects of laboratory management (II)

Overview:
The 'Laboratory Management Committee' will introduce Medical personnel and labor management, Device maintenance contract, and Cost analysis related to the operation of the clinical laboratories, which are essential elements for the laboratory management.

Date & Time	October 18 (Wed), 13:00-14:40	Venue	Grand Hall B (B1)	Language	Korean
Chairs	Kyou-Sup Han, Seoul National University College of Medicine, Korea Hyung Hoi Kim, Pusan National University School of Medicine, Korea
Speakers	1.Medical personnel and labor management for laboratory operation Chang Hee Koo, The Pacific Labor Corporation, Korea 2.Device maintenance contract for laboratory operation Sun Min Lee, Pusan National University Yangsan Hospital, Korea 3.Financial management of laboratory Sang Gon Lee, Green Cross Laboratories, Korea

Symposium 03

Inspector workshop of the Korean laboratory accreditation program

Overview:
This workshop deals with the accreditation checklist and intends to improve understanding and practical skills required to inspection team leader and team members.

Date & Time	October 18 (Wed), 15:00-16:40	Venue	Grand Hall B (B1)	Language	Korean
Chairs	Gye Cheol Kwon, Chungnam National University College of Medicine, Korea Jeong Yeal Ahn, Gachon University School of Medicine, Korea
Speakers	1.Roles and responsibilities of inspection team leader Young Kyung Lee, Hallym University College of Medicine, Korea 2.Internal quality control of coagulation tests Myung-Hyun Nam, Korea University College of Medicine, Korea 3.Quality management in cytogenetic laboratory Kyung-Hee Kim, Gachon University Gil Medical Center, Korea 4.Internal quality control of histocompatibility tests Eun Young Song, Seoul National University College of Medicine, Korea

Plenary Lecture 01

Date & Time	October 18 (Wed), 17:30-18:30	Venue	Walkerhill Theatre (B1)	Language	English
Chair	Sun Hoe Koo, Chungnam National University College of Medicine, Korea
Speaker	Towards an era of precision medicine Jong-Won Kim, Sungkyunkwan University School of Medicine, Korea

October 19 (Thu)

Keynote Speech 01

Date & Time	October 19 (Thu), 08:00-08:50	Venue	Vista Hall 1 (B2)	Language	English
Chair	Won-Ki Min, University of Ulsan, College of Medicine, Korea
Speaker	Artificial intelligence for better health care Ju Han Kim, Seoul National University College of Medicine, Korea

Education Workshop 01   

True minimum inhibitory concentrations, better informed therapeutic choices

Date & Time	October 19 (Thu), 08:00-09:00	Venue	Grand Hall A (B1)	Language	English
Chair	Mi-Na Kim, University of Ulsan College of Medicine, Korea
Speaker	True minimum inhibitory concentrations, better informed therapeutic choices Peisan Lau, Thermo Fisher Scientific, Singapore

Symposium 04

Training and education of laboratory professionals in Asian countries

Overview:
TBD

Date & Time	October 19 (Thu), 08:50-10:50	Venue	Vista Hall 1 (B2)	Language	English
Chairs	Hyosoon Park, Sungkyunkwan University School of Medicine, Korea Ida Parwati, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Indonesia
Speakers	1.Training and education of laboratory medicine in India Praveen Sharma, All India Institute of Medical Sciences, India 2.Education for specialists in clinical laboratory medicine in Japan:Toward a new certification system Toshiyuki Yamada, Jichi Medical University, Japan 3.Education of clinical pathology in Indonesia Budi Mulyono, Indonesian Collegium of Clinical Pathology, Indonesia 4.Training and education of laboratory professionals in Mongolia Oyundelger Munkhtuvshin Ertsuud, Mongolian Association of the Laboratory Medicine, Mongolia 5.Training and education of laboratory professionals in Thailand Panutsaya Tientadakul, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand 6.Education and training requirements for medical laboratory professionals in Vietnam Truong Quan Thuy, Center for Standardization and Quality Control in Medical Laboratory of HCM City (CSQL), Vietnam 7.The role of training and education programs of clinical laboratories in Myanmar Moh Moh Htun, Ministry of Health and Sports, Myanmar 8.Training programs of laboratory medicine in Korea Namhee Ryoo, Keimyung University School of Medicine, Korea

Symposium 05

The shift of management paradigm in clinical microbiology laboratory

Overview:
With the advent of innovative new technology, we need to creatively change our practice of clinical microbiology laboratory. The laboratory automation in clinical microbiology can result in standardization of testing, reducing turnaround times and human resource errors and lowering costs. In this session the changing management of clinical microbiology laboratory to provide rapid, relevant and clinically useful services will be discussed.

Date & Time	October 19 (Thu), 09:00-10:40	Venue	Grand Hall A (B1)	Language	English
Chairs	Miae Lee, Ewha Womans University College of Medicine, Korea Mario Poljak, European Society of Clinical Microbiology and Infectious Diseases, Slovenia
Speakers	1.Laboratory automation in clinical microbiology: A quiet revolution Katja Seme, University of Ljubljana, Slovenia 2.The creative value: 24-hour clinical microbiology laboratory Maurizio Sanguinetti, Catholic University of Rome, Italy 3.Responsible management as a fit clinical microbiologist Sunjoo Kim, Gyeongsang National University School of Medicine, Korea

Symposium 06

Continuous glucose monitoring (CGM), new trends in diabetes management

Overview:
Continuous Glucose Monitoring (CGM) is an emerging technology that provides a continuous measure of interstitial glucose levels. CGM can provide a more complete pattern of glucose excursions to identify fluctuations and trends of blood glucose levels as soon as possible. In this session, an overview of CGM, including principles of technology, clinical uses, evaluation of devices, current challenges, advances in the field, and future directions will be discussed.

Date & Time	October 19 (Thu), 09:00-10:30	Venue	Grand Hall B (B1)	Language	English
Chairs	Samim Choi, Chonbuk National University Medical School, Korea Young Joo Cha, Chung-Ang University Hospital, Korea
Speakers	1.CGM: An overview of its development and clinical application Youngjea Kang, i-SENS, Inc., Korea 2.The role of CGM in today's clinical diabetes management Kun-Ho Yoon, Department of Endocrinology & Metabolism, The Catholic University of Korea, College of Medicine, Korea 3.Clinical experience of RT-CGM using 3 commercially-available devices Hyun Min Kim, Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine, Korea 4.Performance standards of Continuous glucose monitoring Joonseok Park,Hanmi Medicare, Inc.,Korea

Oral Presentation 01: Clinical Chemistry 1

Date & Time	October 19 (Thu), 09:00-10:40	Venue	Grand Hall C (B1)	Language	English
Chairs	Hi Jeong Kwon, College of Medicine, The Catholic University of Korea, Korea Sang Hoon Song, Seoul National University College of Medicine, Korea
Speakers	O-10Prognostic role of high-sensitivity cardiac troponin I and soluble suppression of tumorigenicity-2 in surgical intensive care unit patients after non-cardiac surgery Ahram Yi, Konkuk University School of Medicine, Korea O-11Quantification of thiopurine nucleotides in erythrocytes and clinical application to pediatric acute lymphoblastic leukemia Soo Young Moon, Seoul National University Hospital, Korea O-12The value of monitoring glycated albumin for the prediction of graft outcome of porcine islet transplantation in non-human primates Hee Jung Kang, Hallym University College of Medicine, Korea O-13External quality assurance analysis for free light chain using sigma metrics Hyojin Chae, College of Medicine, The Catholic University of Korea, Korea O-14Association of urine cotinine concentration with coronary artery calcification Hui-Jin Yu, Sungkyunkwan University School of Medicine, Korea O-16A novel liquid chromatography with tandem mass spectrometry method for the analysis of urinary glycosaminoglycans Kyunghoon Lee, Sungkyunkwan University School of Medicine, Korea O-18Evaluating the performance of the variant mode of the HLC-723G11 analyzer in detecting HbA1c Min-Seung Park, Sungkyunkwan University School of Medicine, Korea O-22Technical accuracy of ten self-monitoring blood glucose devices commonly used in dhaka city of Bangladesh Jannatul Nayeem, Bangladesh University of Health Sciences, Bangladesh O-23Clinical and laboratory profiles and outcome of self- poisoning with gloriosa superba tubers in Sri Lanka TM Wijerathna, South Asian Clinical Toxicology Research Collaboration, Sri Lanka

Plenary Lecture 02: AACC-KSLM Select Session

Date & Time	October 19 (Thu), 11:00-12:00	Venue	Vista Hall 1 (B2)	Language	English
Chair	Jeong-Ho Kim, Yonsei University College of Medicine, Korea
Speaker	Saving children’s lives by newborn screening for metabolic disorders Michael J. Bennett, American Association for Clinical Chemistry, USA

Education Workshop 02   

Managing point of care testing through IT solutions with open connectivity

Date & Time	October 19 (Thu), 12:00-13:00	Venue	Vista Hall 1 (B2)	Language	English
Chair	Dal Sik Kim, Chonbuk National University Medical School, Korea
Speaker	Managing point of care testing through IT solutions with open connectivity Kristopher Lam, Healthcare Informatics Specialist, Singapore

Education Workshop 03   

Evaluation of and experiences with the Abbott alinity clinical chemistry and immunoassay systems

Date & Time	October 19 (Thu), 12:00-13:00	Venue	Grand Hall A (B1)	Language	English
Chair	Hyung-Doo Park, Sungkyunkwan University School of Medicine, Korea
Speaker	Evaluation of and experiences with the Abbott alinity clinical chemistry and immunoassay systems Karl J. Lackner, University Medical Center Mainz, Germany

Education Workshop 04   

Intro to ESCMID guideline updates on C. difficile diagnosis and evidence

Date & Time	October 19 (Thu), 12:00-13:00	Venue	Grand Hall B (B1)	Language	English
Chair	Nam Yong Lee, Sungkyunkwan University School of Medicine, Korea
Speaker	Intro to ESCMID guideline updates on C. diff diagnosis and evidence Mark Wilcox, Leeds Teaching Hospitals, UK

Education Workshop 05   

Establishment of reference value of cardiac troponin I

Date & Time	October 19 (Thu), 12:00-13:00	Venue	Grand Hall C (B1)	Language	English
Chair	Hwan Sub Lim, Seoul Clinical Laboratories, Korea
Speaker	Establishment of reference value of cardiac troponin I Sun Min Lee, Pusan National University Yangsan Hospital, Korea

Education Workshop 06   

Laboratory impact of rapid molecular tests for respiratory tract infections

Date & Time	October 19 (Thu), 12:00-13:00	Venue	Cosmos Hall (3F)	Language	English
Chair	Hun-Suk Suh, Daegu Catholic University, Korea
Speaker	Laboratory impact of rapid molecular tests for respiratory tract infections Yu Kyung Kim, Kyungpook National University School of Medicine, Korea

Symposium 07: KSLM-ISLH Joint Symposium

New trends of diagnostic hematology

Overview:
Recently, laboratory diagnostic tests have been progressed remarkably and presented the future vision of precision medicine and targeted therapy. This session is dedicated to present and future laboratory hematology including digital morphology and coagulation tests such as anti phospholipid antibody as well as genetics.

Date & Time	October 19 (Thu), 13:00-14:40	Venue	Vista Hall 1 (B2)	Language	English
Chairs	Sun-Hee Kim, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea Charles S. Eby, Washington University School of Medicine, USA
Speakers	1.Inherited predisposition to myeloid neoplasms Archana Mishra Agarwal, University of Utah/ARUP Laboratories, USA 2.Practical role of lab hematology in precision medicine and targeted therapies: Focus on warfarin pharmacogenetics and thromboelastography guided transfusions in severe trauma Charles S. Eby, Washington University School of Medicine, USA 3.Present and future of digital morphology (in diagnostic hematology) Kyungja Han, The Catholic University of Korea, College of Medicine, Korea 4.Laboratory tests for diagnosis of antiphospholipid syndrome – Especially for determination of lupus anticoagulant Masahiro Ieko, Department of Internal Medicine, Health Sciences University of Hokkaido, Japan

Symposium 08

Molecular diagnosis using cell-free nucleic acids

Overview:
The tremendous development of genomic technologies has enabled the analysis of cell-free nucleic acids, which has enormous potential for the paradigm shift in diagnosis, treatment, and monitoring of diseases. Topics to be presented in this session will focus on the clinical usefulness and prospects of molecular diagnosis using cell-free nucleic acids in the fields of oncology, non-invasive prenatal testing, and transplantation.

Date & Time	October 19 (Thu), 13:00-14:40	Venue	Grand Hall A (B1)	Language	English
Chairs	Yonggoo Kim, College of Medicine, The Catholic University of Korea, Korea Myung-Geun Shin, Chonnam National University Medical School, Korea
Speakers	1.Detecting sub-clinical transplant rejection using minimally-invasive miRNA and mRNA signature Brendan James Keating, University of Pennsylvania School of Medicine, USA 2.New approach of non-invasive prenatal screening using droplet digital PCR Seung Yong Hwang, Department of Molecular and Life Science, Hanyang University, Korea 3.Liquid biopsy: Rapid plasma-based genotyping of cancers Seung-Tae Lee, Yonsei University School of Medicine, Korea

Symposium 09

Globalization of laboratory accreditation program

Overview:
The essential elements required for globalization of laboratory accredation program of Laboratory Medicine Foundation and future perspectives will be discussed at this symposium. The current issues and progress of this project will also be presented.

Date & Time	October 19 (Thu), 13:00-14:40	Venue	Grand Hall B (B1)	Language	English
Chairs	Young Kyung Lee, Hallym University College of Medicine, Korea Cliff Hughes, ISQua and Macquarie University, Australia
Speakers	1.Current issues and future perspectives of quality management in medicine Cliff Hughes, ISQua and Macquarie University, Australia 2.Quality requirements in clinical laboratory Helen Healey, International Society for Quality in Health Care (ISQua), Canada 3.Progress of International Society for Quality in Healthcare (ISQua) accreditation of Laboratory Medicine Foundation (LMF) program Juwon Kim, Yonsei University Wonju College of Medicine, Korea

Oral Presentation 02: Clinical Chemistry 2

Date & Time	October 19 (Thu), 13:00-14:40	Venue	Grand Hall C (B1)	Language	English
Chairs	Young Jun Hong, Korea Cancer Center Hospital, Korea Yeo-Min Yun, Konkuk University School of Medicine, Korea
Speakers	O-15Plasma and urine neutrophil gelatinase-associated lipocalin for the detection of acute kidney injury Ahram Yi, Konkuk University School of Medicine, Korea O-17Stability of ionized calcium under aerobic conditions: Possibilities of underestimation Soo Young Moon, Seoul National University Hospital, Korea O-19Determination of a Korean 99th percentile upper reference limit of cardiac troponin I with Beckman Coulter AccuTnI assay Sun Min Lee, Pusan National University Yangsan Hospital and School of Medicine, Korea O-20Analysis of the correlation between the glycated albumin test and three assays of HbA1C in patients with chronic kidney disease Seung Gyu Yun, College of Medicine Korea University, Korea O-21Quality control strategy for clinical chemistry laboratories using multiple instruments for each measurand Daehyun Chu, University of Ulsan College of Medicine, Korea O-24Establishment of a reference interval for Anti- Müllerian hormone for a Chinese population of normally menstruating women by a fully automated assay Yan Deng, Peking Union Medical College Hospital, Peking Union Medical College, China O-25Calculation of LoB, LoD, and LoQ mass spectrometry assay parameters during method validation Geza Bodor, University of Colorado Anschutz Medical Campus, USA O-26Clinical significance of LDH, CEA, and Beta-2 microglobulin in patients with non-hodgkin lymphoma Garima Gupta, All India Institute of Medical Science, India O-27Vitamin D correction elevates apolipoprotein levels in a sex-specific manner Nasser M. Al-Daghri, College of Science, King Saud University, Saudi Arabia

Symposium 10: AACC-KSLM Select Session

Determining what works: Clinical effectiveness and value based laboratory testing

Overview:
TBD

Date & Time	October 19 (Thu), 15:00-17:00	Venue	Vista Hall 1 (B2)	Language	English
Chairs	You Kyoung Lee, Soonchunhyang University Bucheon Hospital, Korea Mike Hallworth, Royal Shrewsbury Hospital, UK
Speakers	1.Framework for the evaluation of the clinical effectiveness of tests Andrea Rita Horvath, NSW Health Pathology East, Australia 2.Setting minimum clinical performance levels to develop biomarkers for clinical use Andrew St John, ARC Consulting, Australia 3.Patient-centered laboratory medicine – How laboratory testing impacts on outcomes Mike Hallworth, Royal Shrewsbury Hospital, UK

Symposium 11

Biosensors and bioelectronics for immunodiagnostics

Overview:
Current and future techniques of biosensors and bioelectronics for sensitive, multiplex immunoassays

Date & Time	October 19 (Thu), 15:00-16:40	Venue	Grand Hall A (B1)	Language	English
Chairs	Hyon-Suk Kim, Yonsei University College of Medicine, Korea Yunjung Cho, Korea University College of Medicine, Korea
Speakers	1.Optical nanoparticles and their surface modification for sensitive multiplex immunoassays Bong-Hyun Jun, Department of Bioscience and Biotechnology, Konkuk University, Korea 2.Clinical demand of improving immunological diagnostics through the application of biosensors and bioelectronics Sang-Hyun Hwang, University of Ulsan College of Medicine, Korea 3.Highly sensitive in vitro diagnostics using optical nanosensor: Current status and future Jaebum Choo, Department of Bionano Technology, Hanyang University, Korea 4.Biosensing techniques for sensitive immunoassays Haesik Yang, Department of Chemistry, Pusan National University, Korea

Symposium 12

Laboratory preparedness to overcome national threat by infectious diseases through cooperation of public and private diagnostic laboratories

Overview:
As we have experienced in the MERS situation in 2015. public-private cooperation for rapid and accurate diagnosis of national disasters caused by novel infectious diseases is a very important issue. In this session, we discusses the cooperation and role of the national and private laboratories in terms of emergency use of diagnostic kit, national plan for diagnostic laboratory, national reference laboratory, and standardization of quality control material to suggest opinion for future improvement.

Date & Time	October 19 (Thu), 15:00-17:00	Venue	Grand Hall B (B1)	Language	Korean
Chairs	Won Keun Seong, Center for Laboratory Control of Infectious Diseases, Centers for Disease Control & Prevention, Korea Young Uh, Yonsei University Wonju College of Medicine, Korea
Speakers	1.Emergency use authorization of In-Vitro diagnostics for infectious disease in Korea Jae-sun Park, Division of the Laboratory Diagnosis Management, Center for Laboratory Control of Infectious Diseases, Korea 2.National plan for laboratory testing on infectious diseases Cheon Kwon Yoo, Division of the Laboratory Diagnosis Management, Center for Laboratory Control of Infectious Diseases, Korea 3.Establishment of requirements and management systems of a national reference laboratory for infectious diseases Mi-Na Kim, University of Ulsan College of Medicine, Korea 4.Suggestions for external quality assessment to assure the quality of diagnosis for infectious diseases Wee Gyo Lee, Ajou University School of Medicine, Korea

Oral Presentation 03: Diagnostic Genetics

Date & Time	October 19 (Thu), 15:00-16:40	Venue	Grand Hall C (B1)	Language	English
Chairs	Jin-Yeong Han, Dong-A University College of Medicine, Korea Jin Kyung Lee, Korea Cancer Center Hospital, Korea
Speakers	O-45Validation of next-generation sequencing panel for hematologic malignancy Ja-Hyun Jang, Green Cross Laboratories, Korea O-46Experience of an NGS panel testing for patients with endocrine disorder Borahm Kim, Yonsei University College of Medicine, Korea O-47Real-world diagnostic value of targeted panel sequencing in pediatric epilepsy patients John Hoon Rim, Yonsei University College of Medicine, Korea O-48Detection of microdeletion/duplication syndrome using next generation sequencing based-copy number analysis Young-Eun Kim, Greencross Genome, Korea O-49Performance evaluation of QIAGEN’s new NGS platform genereader and BRCA 1/2 panel Eun Jin Lee, University of Ulsan College of Medicine and Asan Medical Center, Korea O-50Validation of a next-generation sequencing panel for noonan spectrum disorders and comparison of bioinformatics tools for variant analysis Chang Ahn Seol, University of Ulsan College of Medicine and Asan Medical Center, Korea O-51The relation of Hoct1 gene expression to hematological and molecular responses to imatinib in patients with chronic myeloid leukemia in the chronic phase Namrata Bhutani, Safdarjung Hospital & VMMC, India O-52Identification of Fam98a as a novel component of stress granules Khondker Ayesha Akter, School of Health and Life Sciences, North South University, Bangladesh O-53Using Mir-10b, Mir-1, and Mir-30a expression profiles of bronchoalveolar lavage and sputum for early detection of non-small cell lung cancer Nosratollah Zarghami, Tabriz University of Medical Sciences, Iran O-54Development of Rolling circle amplification in combination with a biosensor for detection of staphylococcus aureus Zhenbo Xu, South China University of Technology, China

Oral Presentation 04: Diagnostic Hematology & Transfusion Medicine

Date & Time	October 19 (Thu), 15:00-16:40	Venue	Cosmos Hall (3F)	Language	English
Chairs	Dong Soon Lee, Seoul National University College of Medicine, Korea Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea
Speakers	O-1Comparison of three staining methods used in the automated digital cell morphology analyzer, sysmex DI-60 Hyeong Nyeon Kim, Konkuk University School of Medicine, Korea O-2Potential candidates for genetic predisposition to childhood acute myeloid leukemia in 16 Korean patients Namhee Kim, Seoul National University College of Medicine, Korea O-3A study of the effects of hematocrits on systole- diastole differences in blood viscosity Woo Jin Kim, Cheju Halla General Hospital, Korea O-4Extracellular trap formation induces contact system activation and hypercoagulability in hematologic malignancies Tae Yeul Kim, Seoul National University College of Medicine, Korea O-5Prioritization of therapeutic targets in RUNX1- RUNX1T1 fusion-positive acute myeloid leukemia -A bioinformatics approach Sejong Chun, Samsung Medical Center, Korea O-6Effect of deletion 13q on survival in a multiple myeloma patient and comparison of two diagnostic methods: Conventional karyotyping and fluorescent in situ hybridization In Hwa Jeong, Dong-A University College of Medicine, Korea O-7Expression of immune checkpoint molecules (PD-1, PD-L1, and PD-L2) in bone marrow in acute myeloid leukemia Eunkyoung You, University of Ulsan College of Medicine, Korea O-8A differential counter program optimized for bone marrow examinations Young-gon Kim, Korea University, Seoul, Korea O-9The clinical impact of quantitative assessment of FLT3 internal tandem duplication and NPM1 mutation in acute myeloid leukemia Jun Hyung Lee, Chonnam National University Medical School, Korea O-44RhD alloimmunization risk after RhD-incompatible solid organ transplantations in RhD-Negative recipients Ari Ahn, University of Ulsan College of Medicine, Korea

Keynote Speech 02

Date & Time	October 19 (Thu), 17:00-17:40	Venue	Vista Hall 1 (B2)	Language	English
Chair	Kyungwon Lee, Yonsei University College of Medicine, Korea
Speaker	Adding value the role of clinical pathologist and laboratory medicine in reducing antimicrobial resistance Ida Parwati, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Indonesia

Education Workshop 07   

cobas m 511 integrated hematology analyzer: Overview of the technology

Date & Time	October 19 (Thu), 17:00-18:00	Venue	Grand Hall B (B1)	Language	English
Chair	Chan-Jeoung Park, University of Ulsan College of Medicine, Korea
Speaker	cobas m 511 integrated hematology analyzer: Overview of the technology David Zahniser, Chief Scientific Officer, Roche Diagnostics Hematology, USA

October 20 (Fri)

Keynote Speech 03

Date & Time	October 20 (Fri), 08:00-08:40	Venue	Vista Hall 1 (B2)	Language	English
Chair	Chulhun Chang, Pusan National University School of Medicine, Korea
Speaker	Ongoing revolution in clinical microbiology: current status and future perspectives Mario Poljak, European Society of Clinical Microbiology and Infectious Diseases, Slovenia

Symposium 13

CLSI standards: From development to the Korean version

Overview:
TBD

Date & Time	October 20 (Fri), 09:00-10:40	Venue	Vista Hall 1 (B2)	Language	English
Chairs	Do Hoon Lee, National Cancer Center, Korea Min-Jeong Park, Hallym University College of Medicine, Korea
Speakers	1.M100 (Performance standards for antimicrobial susceptibility testing), annually updated: CLSI’s most popular guideline Audrey Schuetz, Mayo Clinic College of Medicine and Science, USA 2.EP15, 3rd Edition – Improving on a CLSI performance evaluation guideline A. Paul Durham, APD Consulting, USA 3.Experience of Korean version of CLSI standards Hee-Jung Chung, National Cancer Center, Korea

Symposium 14

Clinical pharmacogenetic testing & application

Overview:
The patient's response to therapeutic drugs can be various although the degree of variation is different based on characteristics of individual drugs. The pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. This pharmacogenetic information enable the personalized treatment by predicting the patient's drug response. In this section, we will provide useful information about clinical application of pharmacogenetic testing, interpretation, and reporting of the results.

Date & Time	October 20 (Fri), 09:00-10:40	Venue	Grand Hall A (B1)	Language	English
Chairs	Je Hoon Lee, College of Medicine, The Catholic University of Korea, Korea Sail Chun, University of Ulsan, College of Medicine, Korea
Speakers	1.Clinical pharmacogenetics implementation consortium (CPIC) guideline; Using pharmacogenetic tests in patient care Yeo-Min Yun, Konkuk University School of Medicine, Korea 2.KSLM guideline: Korean perspectives and clinically important gene Sollip Kim, Inje University College of Medicine, Korea 3.Implementation of clinical pharmacogenetic testing Soo-Youn Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Oral Presentation 05: Diagnostic Immunology & General Laboratory Medicine

Date & Time	October 20 (Fri), 09:00-10:40	Venue	Grand Hall B (B1)	Language	English
Chairs	Sae Yun Baik, Green Cross Laboratories, Korea Eun-Jee Oh, College of Medicine, Catholic University of Korea, Korea
Speakers	O-40Usefulness of enhanced liver fibrosis, glycosylation isomer of Mac-2 binding protein, Galectin-3, and soluble suppression of tumorigenicity 2 for assessment of liver fibrosis in chronic liver diseases Mikyoung Park, Konkuk University School of Medicine, Korea O-41Clinical use of flow cytometry in the diagnosis of primary immunodeficiency diseases Won Kyung Kwon, Sungkyunkwan University School of Medicine, Korea O-42The laboratory response to the tumor necrosis factor inhibitor in patients with rheumatoid arthritis can be predicted using the autoimmune target test Duck-An Kim, Hanyang University Medical Center, Korea O-43Detection of human T-Cell hyporesponsiveness and DNA damage induced by oxidative stress Kanchana Usuwanthim, Faculty of Allied Health Sciences, Naresuan University, Thailand O-57Clinical, hematological, and biochemical profiling of visceral leishmaniasis patients: A descriptive analysis and comparison of primary and relapsed visceral leishmaniasis Md Golam Hasnain, The University of Newcastle (UoN), New South Wales, Australia O-58Evaluation of clinical laboratory performance using quality indicators in a tertiary care centre Kiran Bhat, Shri Guru Ram Rai Institute of Medical and Health Sciences, India O-59Prevalence of Protozoan parasitic contamination of raw vegetables in Birjand city, Iran, in 2016 Alireza Salehabadi, Birjand University of Medical Sciences, Iran

Oral Presentation 06: Clinical Microbiology

Date & Time	October 20 (Fri), 08:40-10:40	Venue	Grand Hall C (B1)	Language	English
Chairs	Chang Kyu Lee, Korea University College of Medicine, Korea Seok Hoon Jeong, Yonsei University College of Medicine, Korea
Speakers	O-28Evaluation and clinical validation of field-deployable reverse transcription-insulated isothermal PCR assays for detecting the MERS coronavirus Yun Young Go, Korea Research Institute of Chemical Technology, Korea O-29Clinical performance of the SD StrepA ultra test for the diagnosis of streptococcal pharyngitis Sunjoo Kim, Changwon Gyeongsang National University Hospital,Korea O-30Genotyping and macrolide resistance of mycoplasma pneumoniae during a mycoplasma pneumoniae outbreak in Korea Hye-Young Lee, University of Ulsan College of Medicine and Asan Medical Center, Korea O-31The identification of clinical isolates of anaerobic bacteria using the ASTA MALDI-TOF/MS system Dokyun Kim, Yonsei University, College of Medicine, Korea O-32Application of the Xpert® Carba-R assay version 2 to detect carbapenemase-producing organisms using stool and rectal swab of the ICU patients: Quarantine on the way from ICU to general wards Jung-Hyun Byun, Yonsei University School of Medicine, Korea O-33Changing epidemiology of bacterial pathogens over the last 20 years in Korea Mi-Hyun Bae, Hanyang University Guri, Korea O-34Use of MTBDRsl Genotype® assay for characterization of genomic mutations and their patterns in extensively drug-resistant strains Anand Kumar Maurya, All India Institute of Medical Sciences, India O-35Prevalence of bovine tuberculosis and assessment of awareness among cattle owners about its public health implications in selected areas of eastern Ethiopia Jelalu Kemal, Haramaya University, Ethiopia O-36Molecular characterization and rapid detection of gyrA and parC mutations in quinolone-resistant escherichia coli and klebsiella pneumonia clinical isolates by MAMA PCR Ali Pormohammad, School of Medicine, Shahid Beheshti University of Medical Sciences, Iran O-37Antimicrobial resistance surveillance capacity in middle eastern and African regions: Shifting perception, knowledge and behaviour Ernest Tambo,Public Health Pests Laboratory, Jeddah Governorate, Saudi Arabia O-38A comparative study of persistent versus non- persistent candidemia among neonates Majeda Hammoud, Kuwait University, Kuwait O-39Resistance of multi-drug resistant mycobacterium tuberculosis isolates to fluoroquinolones and pyrazinamide and associated genetic mutations in Myanmar Wah Wah Aung, Advanced Molecular Research Centre, Ministry of Health and Sports, Myanmar

Plenary Lecture 03

Date & Time	October 20 (Fri), 11:00-12:00	Venue	Vista Hall 1 (B2)	Language	English
Chair	Kyungja Han, The Catholic University of Korea, College of Medicine, Korea
Speaker	Diagnosis of lymphoid neoplasms: A multimodality approach Elaine S. Jaffe, National Institutes of Health, USA

Education Workshop 08   

Implementation of new real-time PCR assay in infectious diseases

Date & Time	October 20 (Fri), 12:00-13:00	Venue	Vista Hall 1 (B2)	Language	English
Chair	Chae Seung Lim, Korea University College of Medicine, Korea
Speaker	Studies into viral respiratory infections Yonat Shemer-Avni, Soroka University, Israel A new trend in diarrhea diagnosis (Efficacy of multiplex PCR in clinical diagnosis) Jungwon Hyun, Hallym University College of Medicine, Korea

Education Workshop 09   

Diagnosis of liver fibrosis, experience of M2BPGi

Date & Time	October 20 (Fri), 12:00-13:00	Venue	Grand Hall A (B1)	Language	English
Chair	Dae-Soo Moon, Chosun University Hospital, Korea
Speaker	Diagnosis of liver fibrosis, experience of M2BPGi Dong Wook Jekarl, The Catholic University of Korea, Korea

Education Workshop 10   

Advancing clinical microbiology with MALDI-TOF MS: from implementation to beta-lactamase testing.

Date & Time	October 20 (Fri), 12:00-13:00	Venue	Grand Hall B (B1)	Language	English
Chair	Jong Hee Shin, Chonnam National University Medical School, Korea
Speaker	Advancing clinical microbiology with MALDI-TOF MS: From implementation to Beta-Lactamase testing Christopher D. Doern, Virginia Commonwealth University Health System, USA

Education Workshop 11   

Shaping the values of ELISPOT in laboratory medicine: Application in IGRA

Date & Time	October 20 (Fri), 12:00-13:00	Venue	Grand Hall C (B1)	Language	English
Chair	Chang-Ho Jeon, Catholic University of Daegu School of Medicine, Korea
Speaker	Shaping the values of ELISPOT in laboratory medicine: Application in IGRA Kyoung Un Park, Seoul National University College of Medicine, Korea Shaping the values of ELISPOT in laboratory medicine: Application in IGRA Yun Ji Hong, Seoul National University College of Medicine, Korea

Education Workshop 12   

Detection of latent tuberculosis infection in immunocompromised patients using QuantiFERON-TB Gold Plus

Date & Time	October 20 (Fri), 12:00-13:00	Venue	Cosmos Hall (3F)	Language	English
Chair	Seung-Jung Kee, Chonnam National University Medical School, Korea
Speaker	Detection of latent tuberculosis infection in immunocompromised patients using QuantiFERON-TB Gold Plus Eun-Suk Kang, Sungkyunkwan University School of Medicine, Korea

Keynote Speech 04

Date & Time	October 20 (Fri), 13:00-13:40	Venue	Vista Hall 1 (B2)	Language	English
Chair	Soon-Pal Suh, Chonnam National University Medical School, Korea
Speaker	Applications of proteomics and mass spectrometry to laboratory medicine Fumio Nomura, Divisions of Clinical Mass Spectrometry and Clinical Genetics, Chiba University Hospital, Japan

Education Workshop 13   

Serologic diagnosis of allergen sensitization

Date & Time	October 20 (Fri), 13:00-14:00	Venue	Grand Hall B (B1)	Language	English
Chair	Young Ae Lim, Ajou University School of Medicine, Korea
Speaker	Serologic diagnosis of allergen sensitization Jung-Won Park, Internal Medicine, Yonsei University College of Medicine, Korea

Symposium 15

State of the art; Proficiency testing

Overview:
TBD

Date & Time	October 20 (Fri), 14:00-15:20	Venue	Vista Hall 1 (B2)	Language	English
Chairs	Eun Hee Lee, Green Cross Laboratories, Korea Anthony A. Killeen, University of Minnesota, USA
Speakers	1.State of the art: Proficiency testing Anthony A. Killeen, University of Minnesota, USA 2.Korean association of external quality assessment service and proficiency testing Sail Chun, University of Ulsan College of Medicine, Korea

Symposium 16

Patient blood management (PBM)

Overview:
Patient blood management (PBM) aims to optimise, conserve and manage the patient’s own blood requirements thereby minimising or avoiding exposure to allogeneic blood and risks of adverse transfusion reactions. PBM means changing from a product focus to a patient focus and requires a patient specific multidisciplinary team approach in optimising safe, quality care of patients who may need a transfusion thus resulting in improved patient outcomes. In this session, the concept of PBM and its current status in Japan and Europe along with the role of transfusion medicine specialists in PBM will be discussed.

Date & Time	October 20 (Fri), 14:00-15:40	Venue	Grand Hall A (B1)	Language	English
Chairs	Jang Soo Suh, Kyungpook National University School of Medicine, Korea Hyun Ok Kim, Yonsei University College of Medicine, Korea
Speakers	1.What is Patient blood management? Jeong Jae Lee, Department of Obstetrics and Gynecology, Soonchunhyang University Hospital, Korea 2.PBM and the role of specialist in blood bank Kyeong-Hee Kim, Dong-A University College of Medicine, Korea 3.Practice of patient blood management in Japan Eisaburo Sueoka, Saga University Hospital, Japan 4.Patient blood management Fatts Chowdhury, NHSBT and Imperial College Healthcare NHS Trust, UK

Symposium 17

How to improve the quality of our journal?

Overview:
Annals of Laboratory Medicine, affiliated in the Korean Society for Laboratory Medicine, is on the continuous growth in both qualitative and quantitative aspects. Recently, our journal’s impact factor reached upto 2. In front of this new challenge for jump-up, we would like to have the opportunity to recognize our new roles and efforts to be dedicated to improve the quality of our journal.

Date & Time	October 20 (Fri), 14:00-15:40	Venue	Grand Hall B (B1)	Language	English
Chairs	Sunjoo Kim, Gyeongsang National University School of Medicine, Korea Ching-Wan Lam, The University of Hong Kong, China
Speakers	1.Role of editor in scholarly journal Sung-Tae Hong, EIC, Journal of Korean Medical Science, Korea 2.How to maintain the quality of a journal? Ching-Wan Lam, The University of Hong Kong, China 3.How to be a good reviewer Hyun Kyung Kim, Seoul National University College of Medicine, Korea 4.Ann Lab Med: Moving forward Mina Hur, Konkuk University School of Medicine, Korea